-------------------------------------------------------------------------
Balance, June 30,
2007 9,000,000 8,798,787 2,174,008 5,528,059
Transition adjustment - - - -
Net loss for the
period - - - -
Issued under employee
share ownership plan - - - -
Stock-based
compensation - - - 84,746
Shares issued to
directors - - - -
-------------------------------------------------------------------------
Balance, Sept. 30,
2007 9,000,000 8,798,787 2,174,008 5,612,805
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Cumulative
translation
Deficit adjustment Total
$ $ $
------------------------------------------------------------
Balance, June 30,
2006 (53,869,621) (23,379) 23,350,19
Net loss for the
period (2,740,864) - (2,740,864)
Issued under employee
share ownership plan - - -
Stock-based
compensation - - 55,780
Revolving debt
principal payments
made in shares - - 155,434
------------------------------------------------------------
Balance, Sept. 30,
2006 (56,610,485) (23,379) 20,820,54
-----------------------------------------
'/>"/>
| SOURCE Bioniche Life Sciences Inc. Copyright©2007 PR Newswire. All rights reserved |